A post Royal Commission restructure was meant to reset the bar for AMP, but assets have been dumped in what looks like a desperate fire sale. Is there a future?
ResMed has impressed with solid revenue growth across all divisions in the September quarter, while an expanding digital platform is driving re-supply and improving adherence to the company’s products.
Craig Parker of Moat Capital suggests a -20% correction for the ASX200 is looming.
First iron ore from the West Pilbara fines will be introduced to the market in December, underpinning a robust outlook for Fortescue Metals in FY19.
Ahead of the key Christmas trading period, Super Retail has warned sales are sluggish, underscoring the importance of getting the right balance in sales and margin.
Cost inflation has stymied growth in the first weeks of FY19 for Brambles but the company remains confident cost pressures will ease as the year progresses.
CIMIC has reiterated earnings guidance for 2018, although brokers suspect this could be beaten if the strength to September continues to the end of the year.
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.
Peter Switzer of the Switzer Super Report sees the sell-off as a chance to buy, but not yet.
Western Areas’ Odysseus nickel project is now much larger and the economics have improved substantially.
